Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial
Copolymer 1 Multiple Sclerosis Study Group
Research output: Contribution to journal › Article › peer-review
1848Scopus
citations
Fingerprint
Dive into the research topics of 'Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial'. Together they form a unique fingerprint.